When:
Sunday, December 31, 2023 - 12:00am
Our goal is to reduce DHT levels in targeted biological systems. Novel inhibitors have the potential to contribute to the development of therapies for conditions like BPH and AGA by targeting the overproduction of DHT. We are seeking tools and screening capabilities to screen novel substances for their potential to inhibit 5-alpha reductase.